| Literature DB >> 18389136 |
Mark S Tichenor1, Dale L Boger.
Abstract
DNA-binding small molecules are an important source of anticancer therapeutics that display a diverse array of mechanisms of action. Synthetic studies on the new DNA-alkylating natural product yatakemycin, detailed in this Highlight, have served to reassign its structure, assign the absolute stereochemistry, and provide access to yatakemycin and a series of structural analogues for biological evaluation. Studies on the DNA alkylation properties of (+)-and ent-(-)-yatakemycin and related analogues have demonstrated the enhanced DNA alkylation properties of this class of agents and provided insight into their interaction with DNA.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18389136 DOI: 10.1039/b705665f
Source DB: PubMed Journal: Nat Prod Rep ISSN: 0265-0568 Impact factor: 13.423